|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03309 C-MER MEDICAL
Nominal 
2.000 +0.020 (+1.010%) | 2023/12 - Final HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | 361,154 | 164,864 | 144,401 | 109,591 | 136,791 |
| Net Cash from / (used in) Investing Activities | (245,371) | (195,695) | (395,730) | (153,148) | (259,417) |
| Net Cash from / (used in) Financing Activities | (242,877) | 293,679 | 85,123 | 312,016 | (66,606) |
| Increase / (Decrease) in Cash & Cash Equivalents | (127,094) | 262,848 | (166,206) | 268,459 | (189,232) |
| Cash & Cash Equivalents at beginning of period | 644,698 | 386,659 | 553,934 | 282,178 | 471,745 |
| Effect of Foreign Exchange Rate Changes | (4,842) | (4,809) | (1,069) | 3,297 | (335) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 512,762 | 644,698 | 386,659 | 553,934 | 282,178 |
| Remarks: | Real time quote last updated: 25/11/2024 11:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 30,763,000 |
| %Change | 3.377% |
| EPS / (LPS) | HKD 0.025 |
| NBV Per Share ($) | HKD 1.464 |